Fresenius Weighted Average Shares from 2010 to 2024
FMS Stock | USD 19.39 0.42 2.21% |
Check Fresenius Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fresenius main balance sheet or income statement drivers, such as Interest Expense of 234.9 M, Total Revenue of 11.4 B or Gross Profit of 3.7 B, as well as many exotic indicators such as Price To Sales Ratio of 0.28, Dividend Yield of 0.0612 or PTB Ratio of 0.39. Fresenius financial statements analysis is a perfect complement when working with Fresenius Medical Valuation or Volatility modules.
Fresenius | Weighted Average Shares |
About Fresenius Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Fresenius Medical income statement, its balance sheet, and the statement of cash flows. Fresenius Medical investors use historical funamental indicators, such as Fresenius Medical's Weighted Average Shares, to determine how well the company is positioned to perform in the future. Although Fresenius Medical investors may use each financial statement separately, they are all related. The changes in Fresenius Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Fresenius Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Fresenius Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Fresenius Medical. Please read more on our technical analysis and fundamental analysis pages.
KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Fresenius Medical is traded on New York Stock Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Fresenius Medical Correlation against competitors. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Fresenius Stock analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Fresenius Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fresenius Medical. If investors know Fresenius will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fresenius Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.353 | Dividend Share 1.19 | Earnings Share 0.9 | Revenue Per Share 33.1505 | Quarterly Revenue Growth (0) |
The market value of Fresenius Medical Care is measured differently than its book value, which is the value of Fresenius that is recorded on the company's balance sheet. Investors also form their own opinion of Fresenius Medical's value that differs from its market value or its book value, called intrinsic value, which is Fresenius Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fresenius Medical's market value can be influenced by many factors that don't directly affect Fresenius Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fresenius Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fresenius Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fresenius Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.